HPV Test Appropriate After Indeterminate Pap Test (April 29, 2013)
Women who have an indeterminate Pap smear should undergo human papillomavirus (HPV) testing rather than another Pap smear, according to the results of Cochrane Review. Cancer screening refers to the use... Continue Reading
Vaccination against the human papillomavirus (HPV) does not lead to increased sexual activity, according to the results of a study published in the journal Vaccine. HPV is the most common sexually transmitted... Continue Reading
The HPV vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) was found to be safe, according to the results of a large safety study published in the Archives... Continue Reading
A test for the human papillomavirus (HPV) provides information about a woman’s long-term risk of cervical precancers, according to the results of a study published early online in the Journal of Clinical... Continue Reading
The human papillomavirus (HPV) vaccine is reducing infections of virus strains associated with genital warts and cancer, even among those who remain unvaccinated, according to the results of a study published... Continue Reading
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading
According to updated recommendations from the US Preventive Services Task Force, options for cervical cancer screening include a Pap test every three years for women between the ages of 21 and 65, or—for... Continue Reading
Among women diagnosed with invasive cervical cancer, the odds of surviving are better when the cancer is detected by Pap testing than when the cancer is detected because of symptoms. These results were... Continue Reading
Updated results from a large clinical trial of the HPV vaccine Cervarix® (human papillomavirus bivalent [types 16 and 18] recombinant vaccine) confirm its protection against cervical precancer and cancer... Continue Reading
According to a study published in the New England Journal of Medicine, women exposed to diethylstilbestrol (DES) before birth have an increased risk of vaginal cancer, cervical precancers, and breast cancer.... Continue Reading